Instil Bio (TIL) Stock Analysis
NASDAQHealthcareBiotechnology
What Instil Bio does
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Key metrics
ETFs linked to TIL
Broad-market and Healthcare sector ETFs an investor holding Instil Bio is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how TIL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze TIL in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Instil Bio?
- Instil Bio trades under the ticker TIL on NASDAQ.
- Which exchange is TIL listed on?
- TIL is listed on NASDAQ.
- What sector does Instil Bio operate in?
- Instil Bio is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze TIL in a portfolio?
- PortView shows TIL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.